Заранее благодарю!
1. Curr. Top. Med. Chem. 2008, 8, 579-591.
Gaspar M. M., Cruz A., Fraga A. G., Castro A. G., Cruz M. E. M., Pedrosa J.
Developments on drug delivery systems for the treatment of mycobacterial infections.
- DOI:
http://dx.doi.org/10.2174/156802608783955629
Reddy V. M., Bogatcheva E., Einck L., Nacy C. A
Nanoemulsion formulation enhances intracellular activity of capuramycin analogues against Mycobacterium tuberculosis.
- DOI:
http://dx.doi.org/10.2174/2210304x11101020150
Gubernator J., Drulis-Kawa Z., Dorotkiewicz-Jach A., Doroszkiewicz W., Kozubek A.
In vitro antimicrobial activity of liposomes containing ciprofloxacin, meropenem and gentamicin against gram-negative clinical bacterial strains.
- DOI:
http://dx.doi.org/10.2174/157018007784620040
Arias J. L., Martinez-Soler G. I., Lopez-Viota M., Ruiz M. A.
Formulation of chitosan nanoparticles loaded with metronidazole for the treatment of infectious diseases.
- DOI:
http://dx.doi.org/10.2174/157018010790225831
Irache J. M., Merodio M., Arnedo A., Camapanero M. A., Mirshahi M., Espuelas S.
Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs.
- DOI:
http://dx.doi.org/10.2174/1389557053175335
Brandelli A.
Nanostructures as promising tools for delivery of antimicrobial peptides.
- DOI:
http://dx.doi.org/10.2174/138955712801264774